Loading…
Effects of SGI-1027 on Formation and Elimination of PrPSc in Prion-Infected Cells
Recently, SGI-1027, a well-known inhibitor of DNA-methyl transferases (DNMTs), was reported to effectively reduce formation of pathogenic PrP Sc in prion-infected cells. Herein, we confirm the elimination of PrP Sc in chronic wasting disease (CWD) prion-infected neurons by SGI-1027, and pinpoint the...
Saved in:
Published in: | Molecular biology (New York) 2020, Vol.54 (3), p.412-415 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Recently, SGI-1027, a well-known inhibitor of DNA-methyl transferases (DNMTs), was reported to effectively reduce formation of pathogenic PrP
Sc
in prion-infected cells. Herein, we confirm the elimination of PrP
Sc
in chronic wasting disease (CWD) prion-infected neurons by SGI-1027, and pinpoint the binding region of human prion protein to SGI-1027. SGI-1027 is broadly functional against various prion disease types, including human prions. Previously, the inhibitory effects of SGI-1027 on DNMT function is well tested in various cell culture models. While neither treatment with a DNMTs enhancer S-adenosyl-L-methionine (SAM), nor with their inhibitor, 5-azacytidine, prevented PrP
Sc
propagation, SGI-1027 did. Our study suggest that the anti-prion effects of SGI-1027 are a result of its direct interaction with PrP
C
, which effectively interferes with the pathogenic conformational change of PrP
C
to PrP
Sc
. We conclude that SGI-1027 driven suppression of pathogenic PrP
Sc
is independent of DNMT. |
---|---|
ISSN: | 0026-8933 1608-3245 |
DOI: | 10.1134/S0026893320030115 |